As i understand they are targeting there existing client base...

As i understand they are targeting there existing client base and the waitlist .
So this is what you would call a soft launch to make sure everything is functioning correctly in all areas.

Personally would have thought that 8,000 would have been sold out and announcing the next batch by now.
CES, trade shows, hypertension seminars,conferences , winning NIH Radx maternal challenge just to name a small amount i would have assumed a backlog of orders.
The 8 million pipeline for clinical trials was announced in September so slow uptake there.
Has the DOGE cleansing possibly affected the funds available for clinical trials , not sure if related.

There seems to be low selling pressure and patient buyers waiting to buy while news is non- existent.
I think there is a lot happening in the background as the ASX are very tough on what you can put out these days hence the lack of announcements. The 1,500 units was never announced till the quarterly.

I just think this is all game changing and once OTC comes through and no problems with initial 8,000 would expect more social media presence.The BBC ,CGTN and valentines day segments were really poorly done. So some work to be done there.
This will be big but how many more capital raisings are needed to get us there.
Or 1 or 2 big deals simmering in the background that really express the journey.